BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 23201140)

  • 41. Constructing an integrated genetic and epigenetic cellular network for whole cellular mechanism using high-throughput next-generation sequencing data.
    Chen BS; Li CW
    BMC Syst Biol; 2016 Feb; 10():18. PubMed ID: 26897165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer genomics and pathology: all together now.
    Shibata T
    Pathol Int; 2012 Oct; 62(10):647-59. PubMed ID: 23005591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer.
    Roberts NJ; Klein AP
    Cancer Lett; 2013 Nov; 340(2):227-33. PubMed ID: 23196058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy.
    Hagemann IS; Cottrell CE; Lockwood CM
    Cancer Genet; 2013 Dec; 206(12):420-31. PubMed ID: 24388712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Population genomic analysis of model and nonmodel organisms using sequenced RAD tags.
    Hohenlohe PA; Catchen J; Cresko WA
    Methods Mol Biol; 2012; 888():235-60. PubMed ID: 22665285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations.
    Schweiger MR; Kerick M; Timmermann B; Isau M
    Cancer Metastasis Rev; 2011 Jun; 30(2):199-210. PubMed ID: 21267768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studying cancer genomics through next-generation DNA sequencing and bioinformatics.
    Doyle MA; Li J; Doig K; Fellowes A; Wong SQ
    Methods Mol Biol; 2014; 1168():83-98. PubMed ID: 24870132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fusion genes and their discovery using high throughput sequencing.
    Annala MJ; Parker BC; Zhang W; Nykter M
    Cancer Lett; 2013 Nov; 340(2):192-200. PubMed ID: 23376639
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Network-based analysis of omics with multi-objective optimization.
    Mosca E; Milanesi L
    Mol Biosyst; 2013 Dec; 9(12):2971-80. PubMed ID: 24121459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. More Pitfalls Related to Next-generation Sequencing (NGS).
    Sorscher S
    Am J Clin Oncol; 2016 Aug; 39(4):424. PubMed ID: 27465427
    [No Abstract]   [Full Text] [Related]  

  • 51. Next-generation sequencing for lung cancer.
    Wu K; Huang RS; House L; Cho WC
    Future Oncol; 2013 Sep; 9(9):1323-36. PubMed ID: 23980680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Breeding and Genetics Symposium: building single nucleotide polymorphism-derived gene regulatory networks: Towards functional genomewide association studies.
    Reverter A; Fortes MR
    J Anim Sci; 2013 Feb; 91(2):530-6. PubMed ID: 23097399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computational methods and resources for the interpretation of genomic variants in cancer.
    Tian R; Basu MK; Capriotti E
    BMC Genomics; 2015; 16 Suppl 8(Suppl 8):S7. PubMed ID: 26111056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Next-generation sequencing: ready for the clinics?
    Desai AN; Jere A
    Clin Genet; 2012 Jun; 81(6):503-10. PubMed ID: 22375550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition.
    Ku CS; Cooper DN; Iacopetta B; Roukos DH
    Clin Genet; 2013 Jan; 83(1):2-6. PubMed ID: 23020236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. From genomic landscapes to personalized cancer management-is there a roadmap?
    Swanton C; Caldas C
    Ann N Y Acad Sci; 2010 Oct; 1210():34-44. PubMed ID: 20973797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The variation game: Cracking complex genetic disorders with NGS and omics data.
    Cui H; Dhroso A; Johnson N; Korkin D
    Methods; 2015 Jun; 79-80():18-31. PubMed ID: 25944472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetics in human gliomas.
    Kreth S; Thon N; Kreth FW
    Cancer Lett; 2014 Jan; 342(2):185-92. PubMed ID: 22531315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Next generation sequencing technologies in cancer diagnostics and therapeutics: A mini review.
    Li W; Zhao K; Kirberger M; Liao W; Yan Y
    Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):91-102. PubMed ID: 26522064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.
    Zhang J; Liu J; Sun J; Chen C; Foltz G; Lin B
    Brief Bioinform; 2014 Mar; 15(2):244-55. PubMed ID: 23818492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.